3 resultados para Antitumoral

em Universidad de Alicante


Relevância:

10.00% 10.00%

Publicador:

Resumo:

This review highlights the biological importance of many polysubstituted nitro-prolines and -pyrrolidines. Their preparation using asymmetric 1,3-dipolar cycloadditions of azomethine ylides with nitroalkenes using diastereoselective and enantioselective strategies is described remarking the scope and main features of each one.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Se presentan dos localidades para una especie de "Raïm de Pastor" de origen Chino-Japonés (Sedum sarmentosum Bunge), que no había sido citado expresamente en localidades valencianas. Se ha localizado exclusivamente en las localidades de Almudaina, Comarca de El Comtat (Alicante) y en el Portell de Morella, Comarca de Els Ports (Castellón). En la primera localidad se ha podido constatar la facilidad de esta planta para naturalizarse en tejados y repisas, próximos al punto de cultivo, por lo que aunque actualmente es una planta muy rara, habrá que vigilar su comportamiento futuro en las comarcas de montaña valencianas, dada su resistencia al frío y a la sequía. Por otra parte, es una especie con usos medicinales en la tradición china para problemas gástricos, renales y desórdenes hormonales, además, actualmente se está investigando activamente como antitumoral.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Background. It has been reported that the histone deacetylase inhibitor (iHDAc) trichostatin A (TSA) induces an increase in MDR1 gene transcription (ABCB1). This result would compromise the use of iHDACs in combination with other cytotoxic agents that are substrates of P-glycoprotein (Pgp). It has also been reported the use of alternative promoters by the ABCB1 gene and the existence of a traslational control of Pgp protein. Finally, the ABCB1 gene is located in a genetic locus with the nested gene RUNDC3B in the complementary DNA strand, raising the possibility that RUNDC3B expression could interfere with ABCB1 alternative promoter regulation. Methods. A combination of RT-PCR, real time RT-PCR, Western blot and drug accumulation assays by flow cytometry have been used in this study. Results. The iHDACs-induced increase in MDR1 mRNA levels is not followed by a subsequent increase in Pgp protein levels or activity in several pancreatic and colon carcinoma cell lines, suggesting a traslational control of Pgp in these cell lines. In addition, the MDR1 mRNA produced in these cell lines is shorter in its 5' end that the Pgp mRNA produced in cell lines expressing Pgp protein. The different size of the Pgp mRNA is due to the use of alternative promoters. We also demonstrate that these promoters are differentially regulated by TSA. The translational blockade of Pgp mRNA in the pancreatic carcinoma cell lines could be related to alterations in the 5' end of the MDR1 mRNA in the Pgp protein expressing cell lines. In addition, we demonstrate that the ABCB1 nested gene RUNDC3B expression although upregulated by TSA is independent of the ABCB1 alternative promoter used. Conclusions. The results show that the increase in MDR1 mRNA expression after iHDACs treatment is clinically irrelevant since this mRNA does not render an active Pgp protein, at least in colon and pancreatic cancer cell lines. Furthermore, we have demonstrated that TSA in fact, differentially regulates both ABCB1 promoters, downregulating the upstream promoter that is responsible for active P-glycoprotein expression. These results suggest that iHDACs such as TSA may in fact potentiate the effects of antitumoral drugs that are substrates of Pgp. Finally, we have also demonstrate that TSA upregulates RUNDC3B mRNA independently of the ABCB1 promoter in use.